1. What was NOT one of the most common concerns with regard to renal transplant when patients were surveyed directly?

2. What risk factor for rejection is the same risk factor for infection after renal transplant?

3. Which type(s) of cancer are renal transplant recipients at an increased risk of acquiring after transplant?

4. Which medication requires life-long therapeutic drug monitoring after renal transplant?

5. Mr. P is a 67 year-old Caucasian male with a history of heart disease. He is taking atorvastatin, as cholesterol, especially hypertriglyceridemia, has been a particular aspect of his heart disease that has been important to control. The team is considering his immunosuppressive medication after transplant. Which medication may contribute to cardiovascular disease by causing hypertriglyceridemia and may be best to avoid in Mr. P?

6. Based on the meta-analysis published on outcomes associated with nonadherence, what percentage of graft loss was associated with nonadherence?

7. Which of the following quality of life (QOL) tools is considered symptom specific?

8. Which QOL factors studied by Scheel et al were associated with patient-reported nonadherence?

9. Miss. C is a 22 year-old Hispanic female who recently had a kidney transplant for lupus nephritis. She has been identified by the pharmacist to be at particularly high risk of medication non-adherence and the team is hoping to use the pharmacist to help ensure adherence to her transplant medications. She has a smartphone and is willing to learn more about her medications and develop a plan with the team. What types of interventions performed by pharmacists have been published in the literature and may help Miss. C?

10. What was the main finding that Tschida et al found when comparing patients who used the specialty pharmacy resources to those who did not?

« Return to Activity